Middle East and Africa Leukapheresis Market
The Middle East and Africa Leukapheresis Market size was valued at US$ 3.77 Mn in 2021 and is projected to reach US$ 6.20 Mn by 2028, growing at a CAGR of 7.4% during 2021 - 2028.
Report Coverage
- Product Type: Leukapheresis Devices, Leukapheresis Disposables
- Application: Research Applications, Therapeutic Applications
- End User: Blood Component Providers and Blood Centers, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Hospitals and Transfusion Centers
US$ 3.77 Mn
Market size in 2021
US$ 6.20 Mn
Market Size by 2028
7.4%
CAGR, 2021 - 2028
2022-2028
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Middle East and Africa Leukapheresis Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Middle East and Africa Leukapheresis Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Middle East and Africa Leukapheresis Market Regional Analysis
6.2 Middle East and Africa Leukapheresis Market Revenue 2019-2028 (US$ Million)
6.3 Middle East and Africa Leukapheresis Market Forecast Analysis
7. Middle East and Africa Leukapheresis Market Analysis – by Product Type
7.1 Leukapheresis Devices
- 7.1.1 Overview
- 7.1.2 Leukapheresis Devices: Middle East and Africa Leukapheresis Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 Leukapheresis Disposables
- 7.2.1 Overview
- 7.2.2 Leukapheresis Disposables: Middle East and Africa Leukapheresis Market – Revenue and Forecast, 2019-2028 (US$ Million)
8. Middle East and Africa Leukapheresis Market Analysis – by Application
8.1 Research Applications
- 8.1.1 Overview
- 8.1.2 Research Applications: Middle East and Africa Leukapheresis Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.2 Therapeutic Applications
- 8.2.1 Overview
- 8.2.2 Therapeutic Applications: Middle East and Africa Leukapheresis Market – Revenue and Forecast, 2019-2028 (US$ Million)
9. Middle East and Africa Leukapheresis Market Analysis – by End User
9.1 Blood Component Providers and Blood Centers
- 9.1.1 Overview
- 9.1.2 Blood Component Providers and Blood Centers: Middle East and Africa Leukapheresis Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.2 Academic and Research Institutes
- 9.2.1 Overview
- 9.2.2 Academic and Research Institutes: Middle East and Africa Leukapheresis Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.3 Pharmaceutical and Biotechnology Companies
- 9.3.1 Overview
- 9.3.2 Pharmaceutical and Biotechnology Companies: Middle East and Africa Leukapheresis Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.4 Hospitals and Transfusion Centers
- 9.4.1 Overview
- 9.4.2 Hospitals and Transfusion Centers : Middle East and Africa Leukapheresis Market – Revenue and Forecast, 2019-2028 (US$ Million)
10. Middle East and Africa Leukapheresis Market – Middle East and Africa Analysis
10.1 Overview
10.2 Middle East and Africa- 10.2.1 Middle East and Africa Leukapheresis Market Breakdown, by Key Country, 2022 and 2028 (%)
- 10.2.1.1 Middle East and Africa Leukapheresis Market – Revenue and Forecast Analysis – by Country
- 10.2.1.1 South Africa: Middle East and Africa Leukapheresis Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.1.1 South Africa: Middle East and Africa Leukapheresis Market Breakdown, by Product Type
- 10.2.1.1.2 South Africa: Middle East and Africa Leukapheresis Market Breakdown, by Application
- 10.2.1.1.3 South Africa: Middle East and Africa Leukapheresis Market Breakdown, by End User
- 10.2.1.2 Saudi Arabia: Middle East and Africa Leukapheresis Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.2.1 Saudi Arabia: Middle East and Africa Leukapheresis Market Breakdown, by Product Type
- 10.2.1.2.2 Saudi Arabia: Middle East and Africa Leukapheresis Market Breakdown, by Application
- 10.2.1.2.3 Saudi Arabia: Middle East and Africa Leukapheresis Market Breakdown, by End User
- 10.2.1.3 UAE: Middle East and Africa Leukapheresis Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.3.1 UAE: Middle East and Africa Leukapheresis Market Breakdown, by Product Type
- 10.2.1.3.2 UAE: Middle East and Africa Leukapheresis Market Breakdown, by Application
- 10.2.1.3.3 UAE: Middle East and Africa Leukapheresis Market Breakdown, by End User
- 10.2.1.4 Rest of Middle East and Africa: Middle East and Africa Leukapheresis Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.4.1 Rest of Middle East and Africa: Middle East and Africa Leukapheresis Market Breakdown, by Product Type
- 10.2.1.4.2 Rest of Middle East and Africa: Middle East and Africa Leukapheresis Market Breakdown, by Application
- 10.2.1.4.3 Rest of Middle East and Africa: Middle East and Africa Leukapheresis Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Asahi Kasei Corporation
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Fresenius SE & Co. KGaA
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Haemonetics Corporation
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Terumo Corporation
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 STEMCELL Technologies Inc.
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 HemaCare
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Macopharma
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 AllCells
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 BioIVT
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Access the Full M Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.
